You are here: Industry Insights > COVID-19 vaccine

News List

Pfizer and BioNTech publish data from two laboratory studies on COVID-19 vaccine-induced antibodies ability to neutralize SARS-CoV-2 Omicron variant WorldPharmaNews
January 26, 2022
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the publication of new results from two laboratory studies demonstrating that three doses of the Pfizer-BioNTech COVID-19 Vaccine...
Australia Therapeutic Goods Administration (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine prnasia
January 20, 2022
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Australia's Therapeutic Goods Administration...
South Korea grants approval to Novavax Covid-19 vaccine Pharmaceutical-Technology
January 13, 2022
SK bioscience will handle the manufacturing and commercialisation of the vaccine in South Korea.
Pfizer and BioNTech receive U.S. FDA Emergency Use Authorization of COVID-19 vaccine booster for individuals 12 years of age and older WorldPharmaNews
January 05, 2022
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) of a booster dose...
Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in India prnasia
December 29, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute...
Moderna Announces Supply Agreement with South Korea for Additional 20 Million Doses of Moderna’s COVID-19 Vaccine or Updated Booster Candidate in 2022 FirstWordPharma
December 28, 2021
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a revised supply agreement with the government of South Korea for 20 million doses...
COVID-19 Vaccine Developed by WestVac BioPharma Has High Titer Neutralizing Antibodies Against Omicron prnasia
December 27, 2021
WestVac BioPharma Co., Ltd. has achieved a significant progress in the second generation COVID-19 vaccine against the Omicron mutant strain.
Spread of New Variant Reinforces the Need for Comprehensive Diagnostics prnewswire
December 24, 2021
Concerns begin to resurface as the Omicron variant has proven to be a highly contagious continuation of the pandemic. In fact, the number of new cases in the United States over the last 30 days has exceeded 3 million.
Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent Studies prnasia
December 23, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced initial data evaluating the immune response of its COVID-19 vaccine...
World Health Organization SAGE Issues Interim Recommendations for Novavax COVID-19 Vaccine prnasia
December 22, 2021
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the World Health Organization...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page